Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

(NQ: )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Celgene Receives Antitrust Clearance for Juno Acquisition
Celgene Corporation (NASDAQ:CELG) today announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with respect to the previously announced... 
From Business Wire News Releases
NASDAQ:JUNO Investor Alert: Lawsuit Filed in Effort to Halt the Takeover of Juno Therapeutics Inc
San Diego, CA -- (SBWIRE) -- 02/20/2018 -- The Shareholders Foundation announces that an investor, who currently holds NASDAQ:JUNO shares, filed a lawsuit in against the proposed takeover of Juno... 
From SBWire - Latest Press Releases
How CEO's of Biotech are Incentivized and What This Means for Investors
From PR Newswire
Celgene Corporation Commences Tender Offer for Juno Therapeutics, Inc.
Celgene Corporation (NASDAQ:CELG) today announced that its wholly-owned subsidiary, Blue Magpie Corporation, has commenced its previously announced tender offer for all outstanding shares of common... 
From Business Wire News Releases
NASDAQ:JUNO Investor Alert: Investigation of Takeover of Juno Therapeutics Inc
San Diego, CA -- (SBWIRE) -- 02/01/2018 -- An investigation was announced for investors, who currently hold NASDAQ:JUNO shares concerning the takeover of Juno Therapeutics Inc. by Celgene Corporation. 
From SBWire - Latest Press Releases
New Research: Key Drivers of Growth for Guess?, Acer Therapeutics, American National Insurance, J P Morgan Chase, Juno Therapeutics, and Allergan — Factors of Influence, Major Initiatives and Sustaine
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Guess?, Inc. (NYSE:GES),... 
From GlobeNewswire News Releases
The Law Offices of Vincent Wong Reminds Investors of an Investigation of Juno Therapeutics, Inc. in Connection with the Sale of the Company to Celgene Corp.
The Law Offices of Vincent Wong are investigating the Board of Directors of Juno Therapeutics, Inc. 
From Business Wire News Releases
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Juno Therapeutics, Inc. - JUNO
From ACCESSWIRE
The Law Offices of Vincent Wong Notifies Investors of an Investigation of Juno Therapeutics, Inc. in Connection with the Sale of the Company to Celgene Corp.
The Law Offices of Vincent Wong are investigating the Board of Directors of Juno Therapeutics, Inc. 
From Business Wire News Releases
WeissLaw LLP Investigates Juno Therapeutics Inc. Acquisition
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Juno Therapeutics Inc. ("JUNO" or the "Company") (NASDAQ: JUNO) in connection... 
From PR Newswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Juno Therapeutics, Inc. Buyout
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Juno Therapeutics, Inc. Buyout 
From Business Wire News Releases
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Juno Therapeutics, Inc. to Celgene Corp. is Fair to Shareholders
Levi & Korsinsky, LLP reminds investors of an investigation into the fairness of the sale of Juno Therapeutics 
From Business Wire News Releases
SHAREHOLDER ALERT: Monteverde & Associates PC Launches An Investigation of the Board of Directors and Officers of Juno Therapeutics, Inc. - JUNO
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating the Board of... 
From PR Newswire
JUNO THERAPEUTICS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes the Acquisition by Celgene Corporation May be Unfair to Shareholders
Former United States SEC attorney Willie Briscoe is investigating potential claims against the Board of Directors of Juno Therapeutics, Inc. 
From Business Wire News Releases
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Juno Therapeutics, Inc.
Rowley Law PLLC is investigating potential claims against Juno Therapeutics, Inc. (NASDAQ: JUNO) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the... 
From PR Newswire
JUNO THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
JUNO THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout 
From Business Wire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Juno Therapeutics, Inc. to Celgene Corp. is Fair to Shareholders
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Juno Therapeutics 
From Business Wire News Releases
Proskauer Advises Celgene Corporation in Its Acquisition of Juno Therapeutics
International law firm Proskauer represented longtime client Celgene Corporation (NASDAQ: CELG) in its definitive agreement to acquire Juno Therapeutics, Inc. (NASDAQ: JUNO). Under the terms of the... 
From Business Wire News Releases
Johnson Fistel, Announces Investigations of the Proposed Sales of Bioverativ Inc., and Juno Therapeutics, Inc.
Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against Bioverativ Inc., and Juno Therapeutics, Inc., as detailed below: 
From PR Newswire
Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
Celgene Corporation (NASDAQ:CELG) and Juno Therapeutics, Inc. (NASDAQ:JUNO) today announced the signing of a definitive merger agreement in which Celgene has agreed to acquire Juno. Under the terms of... 
From Business Wire News Releases
JUNO THERAPEUTICS INVESTIGATION by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Juno Therapeutics, Inc. - JUNO
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Juno Therapeutics,... 
From Business Wire News Releases
Is it time to buy stock in bluebird bio Inc., Ford, The Goldman Sachs Group and Juno Therapeutics Inc?
InvestorsObserver issues critical PriceWatch Alerts for BLUE, F, GS and JUNO. 
From PR Newswire
JUNO THERAPEUTICS INVESTIGATION BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Juno Therapeutics, Inc. - JUNO
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Juno Therapeutics,... 
From PR Newswire
JUNO THERAPEUTICS INVESTIGATION by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Juno Therapeutics, Inc. - JUNO
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Juno Therapeutics,... 
From Business Wire News Releases
Juno Therapeutics Names Cindy Elkins as Chief Information Officer
Juno Therapeutics Names Cindy Elkins as Chief Information Officer 
From Business Wire News Releases
Quotidian Technical Highlights on Selected Biotech Stocks -- Juno Therapeutics, Acorda Therapeutics, Lexicon Pharma, and FibroGen
From PR Newswire
Juno Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
Juno Therapeutics, Inc. (NASDAQ:JUNO) today announced that it will webcast its presentation at the 36th Annual J.P. Morgan Healthcare Conference at 4:00 p.m. PT on Tuesday, January 9, 2018. The... 
From Business Wire News Releases
Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership
Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher's Cell Therapy Systems (CTS) activation reagents in the manufacturing of its... 
From PR Newswire
Accelerator Corporation Announces Key Senior Leadership Appointments and Name Change to Accelerator Life Science Partners
Accelerator Corporation, a leading life science investment and management firm, today announced the appointments of Kendall Mohler, Ph.D., to the newly created position of chief development officer,... 
From Business Wire News Releases
Juno Therapeutics Highlights Data and Presentations Supporting Best-in-Class Strategy for JCAR017 at ASH
Juno Therapeutics Highlights Data and Presentations Supporting Best-in-Class Strategy for JCAR017 at ASH 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.